121 related articles for article (PubMed ID: 32791502)
21. Polymorphisms in Glycolysis-Related Genes Are Associated with Clinical Outcomes of Paclitaxel-Cisplatin Chemotherapy in Non-Small Cell Lung Cancer.
Choi SH; Jin CC; Do SK; Lee SY; Choi JE; Kang HG; Kim JH; Lee JH; Hong MJ; Lee WK; Jeong JY; Shin KM; Lee YH; Seo H; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
Oncology; 2020; 98(7):468-477. PubMed ID: 32252059
[TBL] [Abstract][Full Text] [Related]
22. Genetic variants of the Wnt signaling pathway as predictors of recurrence and survival in early-stage non-small cell lung cancer patients.
Coscio A; Chang DW; Roth JA; Ye Y; Gu J; Yang P; Wu X
Carcinogenesis; 2014 Jun; 35(6):1284-91. PubMed ID: 24517998
[TBL] [Abstract][Full Text] [Related]
23. The pri-let-7a-2 rs1143770C>T is associated with prognosis of surgically resected non-small cell lung cancer.
Shin KM; Jung DK; Hong MJ; Kang HJ; Lee WK; Yoo SS; Lee SY; Cha SI; Lee J; Kim CH; Seok Y; Cho S; Son JW; Lee EB; Jheon S; Kim YT; Park JY
Gene; 2016 Feb; 577(2):148-52. PubMed ID: 26625972
[TBL] [Abstract][Full Text] [Related]
24. Systematic evaluation of genetic variants in three biological pathways on patient survival in low-stage non-small cell lung cancer.
Pankratz VS; Sun Z; Aakre J; Li Y; Johnson C; Garces YI; Aubry MC; Molina JR; Wigle DA; Yang P
J Thorac Oncol; 2011 Sep; 6(9):1488-95. PubMed ID: 21792076
[TBL] [Abstract][Full Text] [Related]
25. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Neuberg DS; Asomaning K; Su L; Wain JC; Lynch TJ; Giovannucci E; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2239-45. PubMed ID: 17119052
[TBL] [Abstract][Full Text] [Related]
26. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
[TBL] [Abstract][Full Text] [Related]
27. Functional FLT1 Genetic Variation is a Prognostic Factor for Recurrence in Stage I-III Non-Small-Cell Lung Cancer.
Glubb DM; Paré-Brunet L; Jantus-Lewintre E; Jiang C; Crona D; Etheridge AS; Mirza O; Zhang W; Seiser EL; Rzyman W; Jassem J; Auman T; Hirsch FR; Owzar K; Camps C; Dziadziuszko R; Innocenti F
J Thorac Oncol; 2015 Jul; 10(7):1067-75. PubMed ID: 26134224
[TBL] [Abstract][Full Text] [Related]
28. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract][Full Text] [Related]
29. Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.
Wu Y; Liu Z; Tang D; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Lin L; Christiani DC; Wang Q; Wei Q
Transl Res; 2021 Jul; 233():92-103. PubMed ID: 33400994
[TBL] [Abstract][Full Text] [Related]
30. A functional polymorphism on chromosome 15q25 associated with survival of early stage non-small-cell lung cancer.
Jin G; Bae EY; Yang E; Lee EB; Lee WK; Choi JE; Jeon HS; Yoo SS; Lee SY; Lee J; Cha SI; Kim CH; Cho S; Jheon S; Park JY
J Thorac Oncol; 2012 May; 7(5):808-14. PubMed ID: 22722785
[TBL] [Abstract][Full Text] [Related]
31. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
[TBL] [Abstract][Full Text] [Related]
32. KRAS genetic variant as a prognostic factor for recurrence in resectable non-small cell lung cancer.
Sullivan I; Salazar J; Arqueros C; Andrés M; Sebio A; Majem M; Szafranska J; Martínez E; Páez D; López-Pousa A; Baiget M; Barnadas A
Clin Transl Oncol; 2017 Jul; 19(7):884-890. PubMed ID: 28150169
[TBL] [Abstract][Full Text] [Related]
33. Beta-Blocker Use Is Associated With Worse Relapse-Free Survival in Patients With Head and Neck Cancer.
Chen HY; Zhao W; Na'ara S; Gleber-Netto FO; Xie T; Ali S; Thompson ZM; Buell J; Stafford H; Nagarajan P; Davies M; Wong MK; Migden MR; Sharma P; Myers JN; Gross ND; Amit M
JCO Precis Oncol; 2023 Jun; 7():e2200490. PubMed ID: 37285560
[TBL] [Abstract][Full Text] [Related]
34. The prognostic effect of single and multiple cancer-related somatic mutations in resected non-small-cell lung cancer.
Jao K; Tomasini P; Kamel-Reid S; Korpanty GJ; Mascaux C; Sakashita S; Labbé C; Leighl NB; Liu G; Feld R; Bradbury PA; Hwang DM; Pintilie M; Tsao MS; Shepherd FA
Lung Cancer; 2018 Sep; 123():22-29. PubMed ID: 30089591
[TBL] [Abstract][Full Text] [Related]
35.
Mou J; Hu T; Wang Z; Chen W; Wang Y; Zhang W
Aging (Albany NY); 2020 Apr; 12(8):7465-7479. PubMed ID: 32329754
[TBL] [Abstract][Full Text] [Related]
36. Genetic variants in one-carbon metabolism-related genes contribute to NSCLC prognosis in a Chinese population.
Jin G; Huang J; Hu Z; Dai J; Tang R; Chen Y; Xu L; Huang X; Shu Y; Shen H
Cancer; 2010 Dec; 116(24):5700-9. PubMed ID: 20737570
[TBL] [Abstract][Full Text] [Related]
37. Matrix metalloproteinase polymorphisms and survival in stage I non-small cell lung cancer.
Heist RS; Marshall AL; Liu G; Zhou W; Su L; Neuberg D; Lynch TJ; Wain J; Christiani DC
Clin Cancer Res; 2006 Sep; 12(18):5448-53. PubMed ID: 17000679
[TBL] [Abstract][Full Text] [Related]
38. Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.
Yang S; Tang D; Zhao YC; Liu H; Luo S; Stinchcombe TE; Glass C; Su L; Shen S; Christiani DC; Wang Q; Wei Q
Cancer Immunol Immunother; 2021 Oct; 70(10):2819-2833. PubMed ID: 33651148
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
Park JY; Lee WK; Jung DK; Choi JE; Park TI; Lee EB; Cho S; Park JY; Cha SI; Kim CH; Kam S; Jung TH; Jheon S
Clin Cancer Res; 2009 Mar; 15(5):1794-800. PubMed ID: 19240174
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]